NCT04734028View on ClinicalTrials.gov

PTRG-DES Consortium

CompletedOBSERVATIONAL
Enrollment

13,160

Participants

Timeline

Start Date

July 9, 2003

Primary Completion Date

August 7, 2018

Study Completion Date

June 30, 2020

Conditions
Coronary Artery DiseaseClopidogrel, Poor Metabolism ofPlatelet DysfunctionStent Thrombosis
Interventions
DRUG

Clopidogrel Tablets

DES-treated patients were treated with clopidogrel 75 mg daily and aspirin 100 mg daily

Trial Locations (1)

51472

Gyeongsang National University Changwon Hospital, Changwon

All Listed Sponsors
collaborator

Korean Society of Interventional Cardiology

UNKNOWN

lead

Gyeongsang National University Hospital

OTHER

NCT04734028 - PTRG-DES Consortium | Biotech Hunter | Biotech Hunter